Department of Dermatology.
The First Department of Orthopaedic Surgery, The First Hospital of Tianshui, Tianshui, Gansu Province, P.R. China.
Melanoma Res. 2021 Aug 1;31(4):298-308. doi: 10.1097/CMR.0000000000000743.
Melanoma is a malignant tumor with high metastasis and mortality. Epithelial-mesenchymal transition (EMT) was reported to be involved in the growth and metastasis of melanoma. To investigate these sections further, we showed that E26 transformation specific 1 (ETS1) could regulate growth, metastasis and EMT process of melanoma by regulating microRNA(miR)-16/SRY-related HMG box (SOX) 4 expression. MiR-16, ETS1, SOX4 and nuclear factor κB (NF-κB) expression levels in melanoma cells were examined using qPCR. ETS1, SOX4, EMT-related proteins and NF-κB signaling pathway-related proteins were examined using western blot. Cell counting kit-8 assay, transwell assay were applied to evaluate the cell proliferation, migration and invasion of melanoma cells, respectively. Besides, a dual-luciferase reporter assay was employed to verify the binding relationship between ETS1 and miR-16, miR-16 and SOX4, miR-16 and NF-κB1. We showed that ETS1 and SOX4 were upregulated in melanoma cells, while miR-16 was downregulated. MiR-16 overexpression suppressed growth, metastasis and EMT process of melanoma. We found ETS1 could bind to the promoter region of miR-16 and inhibited its transcription. ETS1 silence could inhibit growth, metastasis and EMT process of melanoma, and inhibition of miR-16 could reverse the effects. Besides, miR-16 is directly bound to SOX4 and downregulated its expression. Rescued experiments confirmed that SOX4 overexpression abolished the inhibition effect of miR-16 mimics on growth, metastasis and EMT process of melanoma. Finally, NF-κB1 as the target of miR-16 mediated downstream biological responses. ETS1 activated NF-κB signaling pathway through miR-16 via targeting SOX4, thus promoting growth, metastasis and EMT of melanoma.
黑色素瘤是一种具有高转移和高死亡率的恶性肿瘤。上皮-间充质转化(EMT)被报道参与了黑色素瘤的生长和转移。为了进一步研究这些部分,我们表明 E26 转化特异性 1(ETS1)可以通过调节 microRNA(miR)-16/SRY 相关高迁移率族盒(SOX)4 的表达来调节黑色素瘤的生长、转移和 EMT 过程。使用 qPCR 检测黑色素瘤细胞中 miR-16、ETS1、SOX4 和核因子κB(NF-κB)的表达水平。使用 Western blot 检测 ETS1、SOX4、EMT 相关蛋白和 NF-κB 信号通路相关蛋白的表达水平。应用细胞计数试剂盒-8 测定法、Transwell 测定法分别评估黑色素瘤细胞的增殖、迁移和侵袭。此外,还采用双荧光素酶报告基因测定法验证了 ETS1 与 miR-16、miR-16 与 SOX4、miR-16 与 NF-κB1 之间的结合关系。结果显示,ETS1 和 SOX4 在黑色素瘤细胞中上调,而 miR-16 下调。miR-16 过表达抑制黑色素瘤的生长、转移和 EMT 过程。研究发现 ETS1 可与 miR-16 的启动子区域结合并抑制其转录。沉默 ETS1 可抑制黑色素瘤的生长、转移和 EMT 过程,而抑制 miR-16 可逆转这种作用。此外,miR-16 直接与 SOX4 结合并下调其表达。挽救实验证实,SOX4 过表达可消除 miR-16 模拟物对黑色素瘤生长、转移和 EMT 过程的抑制作用。最后,NF-κB1 作为 miR-16 介导的下游生物学反应的靶标。ETS1 通过靶向 SOX4 激活 miR-16 介导的 NF-κB 信号通路,从而促进黑色素瘤的生长、转移和 EMT。